Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan C Markle

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
JAMA Ophthalmology|June 6, 2024
Melatonin and Risk of Age-Related Macular DegenerationHejin Jeong, Jacqueline K Shaia, Jonathan C Markle, et al.
Eye (London, England)|December 12, 2024
Risk of audiologic side effects with teprotumumab treatment for thyroid eye disease: propensity matched analysisJonathan C Markle, Anil Johanis, Jacqueline K Shaia, et al.
Ophthalmic Surgery, Lasers & Imaging Retina|February 6, 2024
Characterizing the Journey of Geographic Atrophy Patients in Routine Ophthalmic PracticeUrvi Gupta, Christopher M Maatouk, Jonathan C Markle, et al.
Ophthalmic Surgery, Lasers & Imaging Retina|September 23, 2024
Relationship Between Janus Kinase Inhibitor Use and Development of Retinal Vein OcclusionMeghana Chalasani, Jonathan C Markle, Priya Shukla, et al.
Ophthalmology. Retina|May 11, 2025
Risk of Adverse Systemic Events in Retinal Vein OcclusionEmily A Albrecht, Priya Shukla, Alison H Zhao, et al.
Ophthalmic Surgery, Lasers & Imaging Retina|July 25, 2025
Estimated Five-year Risk of Systemic Cardiovascular Events With Anti-VEGF Injections in Neovascular Age-related Macular DegenerationDavid D Chong, Sophie C Yue, James L Raynor, et al.
Cureus|December 29, 2021
Transparency in the Ophthalmology Residency Match: Background, Study, and ImplicationsJonathan C Markle, Harris Ahmed, Kishan Pandya, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
JAMA Ophthalmology|June 6, 2024
Melatonin and Risk of Age-Related Macular DegenerationHejin Jeong, Jacqueline K Shaia, Jonathan C Markle, et al.
Eye (London, England)|December 12, 2024
Risk of audiologic side effects with teprotumumab treatment for thyroid eye disease: propensity matched analysisJonathan C Markle, Anil Johanis, Jacqueline K Shaia, et al.
Ophthalmic Surgery, Lasers & Imaging Retina|February 6, 2024
Characterizing the Journey of Geographic Atrophy Patients in Routine Ophthalmic PracticeUrvi Gupta, Christopher M Maatouk, Jonathan C Markle, et al.
Ophthalmic Surgery, Lasers & Imaging Retina|September 23, 2024
Relationship Between Janus Kinase Inhibitor Use and Development of Retinal Vein OcclusionMeghana Chalasani, Jonathan C Markle, Priya Shukla, et al.
Ophthalmology. Retina|May 11, 2025
Risk of Adverse Systemic Events in Retinal Vein OcclusionEmily A Albrecht, Priya Shukla, Alison H Zhao, et al.
Ophthalmic Surgery, Lasers & Imaging Retina|July 25, 2025
Estimated Five-year Risk of Systemic Cardiovascular Events With Anti-VEGF Injections in Neovascular Age-related Macular DegenerationDavid D Chong, Sophie C Yue, James L Raynor, et al.
Cureus|December 29, 2021
Transparency in the Ophthalmology Residency Match: Background, Study, and ImplicationsJonathan C Markle, Harris Ahmed, Kishan Pandya, et al.
Pageof 1